QT Imaging Holdings Inc Dossier
Qualitative Analysis
Business overview
QT Imaging Holdings, Inc. (Nasdaq: QTI) is a medical device company engaged in the research, development, and commercialization of innovative body imaging systems using low-frequency sound waves. The company's flagship product, the QT Breast Acoustic CT™ Scanner, is an FDA-cleared, non-invasive 3D breast imaging platform that operates without compression, contrast agents, or harmful ionizing radiation. QT Imaging is transforming breast health management by combining proprietary hardware, advanced image reconstruction software, and AI-powered clinical decision tools to address the growing need for precision in breast health, particularly for women with dense breast tissue.
Research as of 19 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Transitioning the business model from a traditional hardware-only medical device manufacturer to a scalable, high-margin Software-as-a-Service (SaaS) and biomarker-driven medical imaging franchise. The platform delivers cloud-based AI/ML algorithms, automated lesion segmentation, and quantitative feature extraction directly to connected Breast Acoustic CT systems.
Expected impact: Improves gross margins over time, establishes recurring subscription revenue streams, and enhances clinical utility through continuous cloud-delivered software updates.
Expanding commercial footprint through high-impact exclusive distribution agreements. Key partnerships include NXC Imaging in the United States, and Gulf Medical Company and Al Naghi Medical in the Middle East.
Expected impact: Secures predictable, multi-year hardware revenue (e.g., over $33 million from Gulf Medical and over $24 million from UAE/regional partners) and expands the global install base for the QTI Cloud Platform.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Strategic Partnerships
Enables the integration of Olea Medical's advanced visualization, quantitative analytics, and AI-ready imaging technologies into the QTI Cloud Platform. This collaboration resulted in the launch of the QTI Imaging-Olea Viewer, which allows clinicians to correlate findings across multiple breast imaging modalities (mammography, MRI, ultrasound, and QTscan) in a single interface.
Terms: Specific financial terms of the collaboration were not disclosed, but QT Imaging distributes the customized viewer software.
Establishes the deployment of InteleShare Research PACS and Cloud PACS across QT Imaging's clinical research and commercial networks. This provides the secure, cloud-based backbone required to deliver the QTI Cloud SaaS Platform, allowing seamless image archiving, anonymization, and multi-institutional data sharing.
Terms: Terms of the agreement were not publicly disclosed.
GMC serves as the exclusive distributor of QTI Breast Acoustic CT scanners and QTI Cloud Platform subscriptions in Saudi Arabia, addressing a critical regional need for radiation-free breast imaging in younger women.
Terms: Provides for minimum order quantities of five scanners per quarter starting in Q1 2026 through 2028, totaling a minimum of 60 scanners and projected revenue of more than $33 million.